(Q37963480)

26 August 2017

Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses (English)

1 reference

26 August 2017

0 references

K J Laing

1

1 reference

26 August 2017

L Dong

2

1 reference

26 August 2017

J Sidney

3

1 reference

26 August 2017

A Sette

4

1 reference

26 August 2017

D M Koelle

5

1 reference

26 August 2017

1 January 2012

1 reference

Clinical and Experimental Immunology

26 August 2017

1 reference

26 August 2017

167

1 reference

26 August 2017

1

1 reference

26 August 2017

47-58

1 reference

Once-daily valacyclovir to reduce the risk of transmission of genital herpes

26 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Effect of herpes simplex suppression on incidence of HIV among women in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Effects of HIV-1 and herpes simplex virus type 2 infection on lymphocyte and dendritic cell density in adult foreskins from Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Reevaluating the CD8 T-cell response to herpes simplex virus type 1: involvement of CD8 T cells reactive to subdominant epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

The presence of lytic HSV-1 transcripts and clonally expanded T cells with a memory effector phenotype in human sensory ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Evolution of recurrent herpes simplex lesions. An immunohistologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

The herpes simplex virus 1 UL17 protein is the second constituent of the capsid vertex-specific component required for DNA packaging and retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Expression of the HSV-1 capsid protein VP19C in Escherichia coli: a single amino acid change overcomes an expression block of the full-length polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

HLA-DQ tetramers identify epitope-specific T cells in peripheral blood of herpes simplex virus type 2-infected individuals: direct detection of immunodominant antigen-responsive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Rapid epitope identification from complex class-II-restricted T-cell antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Intraocular T cells of patients with herpes simplex virus (HSV)-induced acute retinal necrosis recognize HSV tegument proteins VP11/12 and VP13/14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

The antiapoptotic herpes simplex virus glycoprotein J localizes to multiple cellular organelles and induces reactive oxygen species formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Epitope mapping of full-length glycoprotein D from HSV-2 reveals a novel CD4+ CTL epitope located at the transmembrane-cytoplasmic junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Differences in the recognition of CTL epitopes during primary and secondary responses to herpes simplex virus infection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Defining the herpes simplex virus-specific CD8+ T cell repertoire in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Detailed characterization of T cell responses to herpes simplex virus-2 in immune seronegative persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Immunogenicity of herpes simplex virus type 1 mutants containing deletions in one or more alpha-genes: ICP4, ICP27, ICP22, and ICP0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Delaying the expression of herpes simplex virus type 1 glycoprotein B (gB) to a true late gene alters neurovirulence and inhibits the gB-CD8+ T-cell response in the trigeminal ganglion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

A heat shock protein based polyvalent vaccine targeting HSV-2: CD4(+) and CD8(+) cellular immunity and protective efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Monophosphoryl lipid A and QS21 increase CD8 T lymphocyte cytotoxicity to herpes simplex virus-2 infected cell proteins 4 and 27 through IFN-gamma and IL-12 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Phase I Dose-Escalation Study of a Monovalent Heat Shock Protein 70-Herpes Simplex Virus Type 2 (HSV-2) Peptide-Based Vaccine Designed To Prime or Boost CD8 T-Cell Responses in HSV-Naive and HSV-2-Infected Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Knowledge-based virtual screening of HLA-A*0201-restricted CD8+ T-cell epitope peptides from herpes simplex virus genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

High-resolution HLA alleles and haplotypes in the United States population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Four-locus high-resolution HLA typing in a sample of Mexican Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Molecular variation at the HLA-A, B, C, DRB1, DQA1, and DQB1 loci in full heritage American Indians in Arizona: private haplotypes and their evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

HLA-A, -B, -C, -DRB1 allele and haplotype frequencies in an African American population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

HLA-A, -B, -C, and -DRB1 allele and haplotype frequencies distinguish Eastern European Americans from the general European American population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

HLA class I transgenic mice: development, utilisation and improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Definition of supertypes for HLA molecules using clustering of specificity matrices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

HLA class I supertypes: a revised and updated classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Evidence for differences in immunologic and pathogenesis properties of herpes simplex virus 2 strains from the United States and South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Public TCR use by herpes simplex virus-2-specific human CD8 CTLs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Immunology. Painful failure of promising genital herpes vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Immune surveillance in the skin: mechanisms and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Dynamic programming of CD8+ T cell trafficking after live viral immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Homing in on the cellular immune response to HSV-2 in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Antigen-specific T cells localize to the uterine cervix in women with genital herpes simplex virus type 2 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Development of an interferon-gamma ELISPOT assay to detect human T cell responses to HSV-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Herpes Simplex Virus-Specific Memory CD8+ T Cells Are Selectively Activated and Retained in Latently Infected Sensory Ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Persistence of herpes simplex virus type 2 VP16-specific CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Epitope mapping of HSV-1 glycoprotein K (gK) reveals a T cell epitope located within the signal domain of gK

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

The role of a glycoprotein K (gK) CD8+ T-cell epitope of herpes simplex virus on virus replication and pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Potent protective cellular immune responses generated by a DNA vaccine encoding HSV-2 ICP27 and the E. coli heat labile enterotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Dendritic Cell-Induced Memory T Cell Activation in Nonlymphoid Tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2011.04502.X

Frequencies of HLA-A2 alleles in five U.S. population groups. Predominance Of A*02011 and identification of HLA-A*0231

21 January 2018

1 reference

12 December 2020

Polymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes

1 reference

12 December 2020

Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes.

1 reference

12 December 2020

Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions

1 reference

12 December 2020

Lymphocytes delay kinetics of HSV-1 reactivation from in vitro explants of latent infected trigeminal ganglia

1 reference

12 December 2020

Lymphocyte trafficking and regional immunity.

1 reference

12 December 2020

T Cell Immunity to Herpes Simplex Viruses in Seronegative Subjects: Silent Infection or Acquired Immunity?

1 reference

12 December 2020

Herpes simplex virus glycoprotein D is recognized as antigen by CD4+ and CD8+ T lymphocytes from infected mice. Characterization of T cell clones.

1 reference

12 December 2020

Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens

1 reference

12 December 2020

Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins

1 reference

12 December 2020

Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions.

1 reference

12 December 2020

10.1111/J.1365-2249.2011.04502.X

Identifiers

DOI

1 reference

26 August 2017

0 references

1 reference